Abstract: The present invention provides an anti-inflammatory composition for treatment of joint and muscle pain through transdermnal delivery of a capsacinoid in conjunction with glucosamine. The ingredients of the composition of the present invention, namely, a capsacinoid in combination with a primary amine, such as glucosamine, at a high concentration, interact in a synergistic manner to provide a prolonged effect of pain relief when used in the treatment of joint and/or muscle pain associated with an inflammatory response. The prolonged pain relief effect is achieved without incurring the intense burning or stinging sensation usually associated with topical capsaicin administration. The present invention also provides methods for relieving joint and/or muscle pain associated with an inflammatory response, which employ the composition of the present invention.

Abstract: The present invention relates to novel aromatic cyanate ester compounds containing at least two rings linked by a group containing an unsaturated group. The present invention further relates to compositions and prepolymers of said novel aromatic cyanate ester compounds. The present invention further relates to a process for preparing said compounds and cured articles resulting from curable mixtures thereof.

Abstract: Curable mixtures suitable for the manufacture of moldings, coatings and foams comprises a) an epoxy resin having more than one 1,2-epoxy group per molecule, b) as curing catalyst, an imidazole compound of formula I wherein R1, R2 and R3 are each independently of the others a hydrogen atom, a halogen atom, alkyl having from 1 to 20 carbon atoms, alkoxy having from 1 to 20 carbon atoms, unsubstituted or halo-, nitro-, C1-4alkyl- or C1-4alkoxy-substituted aralkyl having from 7 to 20 carbon atoms, or unsubstituted or halo-, nitro-, C1-4alkyl- or C1-4alkoxy-substituted aryl having from 6 to 20 carbon atoms, and R4 is alkyl having from 1 to 20 carbon atoms, alkenyl having from 2 to 20 carbon atoms, alkynyl having from 2 to 20 carbon atoms, unsubstituted or halo-, nitro-, C1-4alkyl- or C1-4alkoxy-substituted aralkyl having from 7 to 20 carbon atoms or unsubstituted or halo-, nitro-, C1-4alkyl- or C1-4alkoxy-substituted aryl having from 6 to 20 carbon atoms; and c) curing agent such as dicyadiami

Abstract: Powder coating compositions comprise a binder selected from carboxyl-group-containing polyesters, carboxyl-group-containing poly(meth)acrylates and mixtures of the said substances, and one or more epoxy compounds, wherein the epoxy compounds comprise at least one compound of formula (I) that is solid at 25° C.

Abstract: The present invention relates to a powder coating composition containing as binder one or more than one poly(meth)acrylic resin having free carboxyl groups and, as hardener for these poly(meth)acrylic resins, one or more than one epoxy resin having a molecular weight of up to 1500, wherein the epoxy resins comprise at least 70% by weight of glycidyl esters which are selected from the group consisting of aliphatic and cycloaliphatic polyglycidyl polycarboxylates. More particularly, the present invention relates to a coating composition, which is free of carboxyl-functional polyesters, comprising a binder consisting of one or more than one poly(meth)acrylic resin having free carboxyl groups and, as hardener for the poly(meth)acrylic resin, one or more than one epoxy resin having a molecular weight of up to 1500, wherein the epoxy resin is a cycloaliphatic polyglycidyl polycarboxylate or mixtures thereof.

Abstract: The present invention relates to the curative component of poly urethane/urea-forming casting compositions containing (a) an aromatic polyamine containing at least one thioether group, (b) a phosphate ester and (c) an aldehyde or a compound which forms an aldehyde upon reaction with water. Component (c) prevents the composition from discoloring with time into an unacceptable dark color and also neutralises the strong odor resulting from the amine curative and its decomposition byproducts.

Abstract: The present invention relates to compositions of matter containing aromatic cyanate ester containing at least two rings linked by a group containing an unsaturated group and selected aromatic hydroxyl compounds that exhibited improved heat release and curing properties. The present invention further relates to a process for preparing said compounds and cured articles resulting from curable mixtures thereof.

Abstract: The present invention relates to non-psychoactive derivatives of tetrahydro-cannabinol, which exhibit anti-inflammatory, analgesic and leukocyte antiadhesion activities. The invention includes novel derivatives of (3R,4R)-&Dgr;8-tetrahydrocannabinol-11-oic acids [hereinafter referred to as (3R,4R)-&Dgr;8-THC-11-oic acid], as well as pharmaceutical compositions containing the (3R,4R)-&Dgr;8-THC-11-oic acid derivatives. The invention further covers methods of administering the novel derivatives and pharmaceutical compositions as therapeutic agents in the treatment of pain and tissue inflammation. Non-psychoactive derivatives of &Dgr;8-THC-11-oic acid are described which have analgesic and anti-inflammatory properties.

Abstract: An epoxy resin mixture is prepared by a) the reaction of (i) a diglycidyl compound, (ii) a bisphenol compound and (iii) at least one monophenol at temperatures of from 160 to 170° C. in the presence of an advancement catalyst that can be thermally deactivated, (b) upon completion of the reaction, the catalyst is deactivated by heating to a temperature of approximately 180° C. wherein (A1) one or more epoxy resins having an epoxy functionality of greater than two is added, and c) the resulting epoxy resin mixture is homogenized at that temperature.

Abstract: The present invention relates to a process for the production of three-dimensional articles by stereolithography using a radiation-curable composition comprising a mixture of at least one cationically polymerizable compound and/or at least one free radical polymerizable compound, at least one filler material and at least one photoinitiator for cationic and/or radical polymerization. An organic viscosity stabilizer material may be brought into contact with the composition to substantially delay or prevent undesirable viscosity increase and subsequently premature polymerization. A filler material is optionally added to the composition in an effective amount to at least delay or prevent a significant increase in viscosity and polymerization. The process is particularly suitable for stabilizing resins in stereolithography baths.

Abstract: An unsaturated polyester (i) having a weight-average molecular weight (Mw) of 1,000-100,000 and at least two carbon-carbon unsaturated bonds in the molecule thereof obtained by esterifying an unsaturated carboxylic acid (b) with a polyester-polyol (a) obtained by subjecting a polybasic carboxylic acid containing polymerized fatty acid and/or polymerize fatty acid ester to polycondensation with a polyhydric alcohol; and an unsaturated (poly)urethane having Mw of 1,000-100,000 and at least two carbon-carbon unsaturated bonds in molecule obtained by reacting said polyester-polyol (a), polyisocyanate (d) and compound (e) having active hydrogen and polymerizable carbon-carbon unsaturated bond. Said unsaturated polyester and unsaturated (poly)urethane exhibit excellent adhesive property, heat resistance, water resistance and flexibility after being cured.

Abstract: The present invention relates to a high voltage liquid-filled transformer including a housing and a dielectric liquid impregnated barrier material within the housing. The barrier material is prepared from an expandable epoxy resin formulation comprising: (i) at least one polyglycidyl compound; (ii) at least one curing agent for the polyglycidyl compound; and (iii) at least one blowing agent. An additional aspect of the present invention is a novel barrier component for a liquid-filled transformer. The present invention also relates to a method for manufacturing the novel barrier component. The present invention also relates to a method of manufacturing the transformer.

Abstract: Chimeric molecules comprising a virus targeting antisense oligonucleotide moiety attached to an activator of 2-5A-dependent RNase.

Abstract: The present invention relates to a compound according to formula (1) wherein n is 0, 2, 4 or 6 and a, b and c are, independently of one another, 1 or 0. R1-1a, R1-1b and R1-1c are hydrogen, a hydrocarbyl containing 1 to 10 carbon atoms which are alkyl, aryl, alkylene, arylalkyl or alkylaryl or a hydrocarbyl containing 1 to 10 carbon atoms and at least one heteroatom which can be oxygen, sulfur or nitrogen. R2-1a, R3-1a, R4-1a, R5-1a, R2-1b, R3-1b, R4-1b, R5-1b, R2-1c, R3-1c, R4-1c and R5-1c hydrogen or C1-C4alkyl. R6-1a, R7-1a, R6-1b, R7-1b, R6-1c and R7-1c are C1-C4akyl. A is an aromatic or alicyclic ring having 5 to 7 carbon atoms. The present invention further relates to a Mannich base reaction product obtained by combining an extract from cashew nutshell liquid with at least one aromatic or alicylic polyamine and at least one aldehyde compound, epoxy resin compositions and curable formulations containing the same, and methods for using such compositions.

Abstract: A curable composition is described, comprising a) 10 to 90% by weight of at least one, optionally water-dilutable, water-emulsifiable or water-dispersible, epoxy resin having more than one epoxy group in the molecule; b) 90 to 10% by weight of at least one polyamine adduct which predominantly corresponds to the idealised formula (I) and which is prepared from an adduct of formula (A) and a polyamine of formula (XII), wherein the sum of the percentages by weight of components (a) and (b) is always 100%; c) optionally, at least one further aliphatic, cycloaliphatic, aromatic/aliphatic, aromatic or heteroaromatic mono- or polyamine which may optionally be modified by adduction; and d) optionally, at least one customary additive, R1 and R2 and also m and n and B being defined in more detail in the description. The novel compositions are used for the preparation of colourants and coatings.

Abstract: The present invention relates to methods of inhibiting infection by RNA viruses with complexes of an activator of RNase L and an oligonucleotide that is capable of binding to the genome, antigenome or mRNAs of a negative strand RNA virus to specifically cleave the genomic or antigenomic RNA strand of the virus. In accordance with the present invention, the methods and complexes of the invention may be applied to target any negative strand RNA virus. The invention in one embodiment relates to a covalently linked complex of an oligonucleotide that is capable of binding to the genomic or antigenomic template RNA strand of a negative strand RNA virus and/or binding to an mRNA of a viral protein (an “antisense oligonucleotide”) coupled to an activator of RNase L. In a preferred embodiment of the present invention, the oligonucleotide component of the complex is complementary to a region of the viral genomic RNA strand characterized by repeated or consensus sequences.